SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-522422"
 

Search: onr:"swepub:oai:DiVA.org:uu-522422" > Ex vivo assessment ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases

Cashin, Peter, 1984- (author)
Uppsala universitet,Gastrointestinalkirurgi
Söderström, Maria (author)
Uppsala universitet,Institutionen för kirurgiska vetenskaper
Blom, Kristin (author)
Uppsala universitet,Institutionen för medicinska vetenskaper
show more...
Artursson, Sara (author)
Uppsala universitet,Gastrointestinalkirurgi
Andersson, Claes (author)
Uppsala universitet,Institutionen för medicinska vetenskaper
Larsson, Rolf (author)
Uppsala universitet,Institutionen för medicinska vetenskaper
Nygren, Peter (author)
Uppsala universitet,Institutionen för immunologi, genetik och patologi
show less...
 (creator_code:org_t)
2023-03-15
2023
English.
In: British Journal of Surgery. - : Oxford University Press. - 0007-1323 .- 1365-2168. ; 110:9, s. 1080-1083
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Patients with peritoneal metastasis from colorectal cancer (PMCRC) may have a chance of cure when treated with cytoreductive surgery (CRS) combined with heated intraperitoneal chemotherapy (HIPEC)1–5.Choice of chemotherapy for HIPEC has been based on knowledge of its systemic effects, pharmacokinetics, technical feasibility, hyperthermic efficacy enhancement, and tolerance6–8. Selection of cancer drugs for treatment based on phenotypical assessment of patient cancer cell drug sensitivity ex vivo is one approach to personalized cancer treatment. One technique for this is the fluorometric microculture cytotoxicity assay (FMCA) that has been used in drug development and for the development of personalized cancer medicine9–16.This study investigated whether ex vivo assessment of drug sensitivity by the FMCA provides predictive information in terms of peritoneal recurrence-free survival (PRFS) and overall survival (OS) in patients treated with CRS and HIPEC for isolated PMCRC.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kirurgi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Surgery (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view